Erbil Shaban
“Explosion in interest”: How guidelines will shape future of PE treatment
Experts in pulmonary embolism (PE) treatment give their views on how they see the fast-developing space shaping up in the coming years.
The burgeoning PE care landscape, part two: “Moving the needle to...
In part two of our special focus on the pulmonary embolism (PE) treatment landscape, Patrick Muck (Good Samaritan Hospital, Cincinnati, USA) is joined by...
New developments in deep venous disease: “Do we really need a...
Leading venous specialist Stephen Black (Guy’s and St Thomas’ NHS Foundation Trust, London, UK) analyses the burgeoning venous stenting landscape during a sit-down with...
Further research planned for CVO stenting prognostic tool
Last year, Mohammad Barbati (Munich, Germany) spoke to Venous News at the 28th European Vascular Course (EVC; 9–11 March, Maastricht, The Netherlands), highlighting his...
EVC 2025: PE interventions “should be part of the armamentarium of...
Makis Avgerinos (Athens, Greece), co-director of the venous programme for the European Vascular Course (EVC), speaks to Venous News at this year’s meeting (9–11...
STEVECO trial catalyzes need for “a new era” of post-thrombotic syndrome...
Before the STEVECO trial, there were no randomized controlled trial data in the chronic disease space; in its wake, has come a more robust...
Ensuring the right treatment for patients with PE and DVT
In this short video, Michael Kostrzewa (Baden, Switzerland) and Rashid Akhtar (London, UK) discuss the latest approaches to the treatment of acute pulmonary embolism...